IRIS
RUPERTO, NICOLINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.979
NA - Nord America 988
AS - Asia 970
Continente sconosciuto - Info sul continente non disponibili 207
SA - Sud America 82
AF - Africa 22
OC - Oceania 3
Totale 8.251
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.825
US - Stati Uniti d'America 919
SG - Singapore 353
CN - Cina 215
VN - Vietnam 148
BD - Bangladesh 140
FR - Francia 56
BR - Brasile 51
HK - Hong Kong 39
FI - Finlandia 31
CA - Canada 27
DE - Germania 14
AR - Argentina 12
GB - Regno Unito 12
JP - Giappone 12
CR - Costa Rica 10
IN - India 9
EC - Ecuador 8
ID - Indonesia 8
IQ - Iraq 7
JM - Giamaica 6
RU - Federazione Russa 6
SE - Svezia 6
CH - Svizzera 5
DZ - Algeria 5
KE - Kenya 5
MX - Messico 5
TR - Turchia 5
TW - Taiwan 5
HN - Honduras 4
NL - Olanda 4
PK - Pakistan 4
TH - Thailandia 4
VE - Venezuela 4
AT - Austria 3
BY - Bielorussia 3
CO - Colombia 3
EG - Egitto 3
IL - Israele 3
BS - Bahamas 2
CL - Cile 2
GT - Guatemala 2
IE - Irlanda 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PL - Polonia 2
PR - Porto Rico 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
ES - Italia 1
GM - Gambi 1
GR - Grecia 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TG - Togo 1
TJ - Tagikistan 1
UA - Ucraina 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
Totale 8.044
Salva come PNG Salva come JPEG
Città #
Genova 2.907
Genoa 1.789
Rapallo 521
Vado Ligure 468
San Jose 220
Singapore 176
Ashburn 163
Beijing 48
Lauterbourg 46
New York 45
Ho Chi Minh City 41
Hong Kong 38
Hanoi 37
Helsinki 31
Santa Clara 28
Council Bluffs 17
Los Angeles 16
Buffalo 15
Chicago 15
Haiphong 13
Bordighera 12
Frankfurt am Main 10
Tokyo 10
Naples 9
Orem 9
Milan 8
Montreal 8
Bologna 7
Dallas 7
London 7
North Bergen 7
Rome 7
Charlotte 6
San José 6
Alessandria 5
Da Nang 5
Las Vegas 5
Phoenix 5
Portland 5
Princeton 5
São Paulo 5
The Bronx 5
Zurich 5
Amsterdam 4
Boardman 4
Guayaquil 4
Hillsboro 4
Montoro 4
Nairobi 4
Palermo 4
Queens 4
Toronto 4
Washington 4
Baghdad 3
Bangkok 3
Bridgeport 3
Can Tho 3
Canton 3
City of London 3
Cleveland 3
East Brunswick 3
Florence 3
Hempstead 3
Istanbul 3
Lake Worth 3
Lithonia 3
Lynnwood 3
Miami 3
Nuremberg 3
Paris 3
Phủ Lý 3
Quito 3
Rio de Janeiro 3
Rochester 3
San Francisco 3
Shanghai 3
Sona 3
Staten Island 3
Sunnyvale 3
Tianjin 3
Abbeville 2
Abingdon 2
Alajuela 2
Amman 2
Antioch 2
Biên Hòa 2
Blumenau 2
Bogotá 2
Brasília 2
Buenos Aires 2
Bắc Ninh 2
Carapicuíba 2
Cardiff 2
Changsha 2
Chennai 2
Columbus 2
Delhi 2
Des Moines 2
East Wenatchee 2
Fort Lauderdale 2
Totale 6.953
Salva come PNG Salva come JPEG
Nome #
Development and validation of a composite disease activity score for juvenile idiopathic arthritis 238
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis 221
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis 209
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 208
2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative 208
Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score 207
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in juvenile dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation collaborative initiative 201
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects 195
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 194
Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study 190
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 189
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 188
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 180
Development and testing of a hybrid measure of muscle strength in juvenile dermatomyositis for use in routine care 176
Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. 172
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy 171
A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry 169
Performance of different diagnostic criteria for familial Mediterranean fever in children with periodic fevers: Results from a multicenter international registry 162
Clinical trials in children and adolescents with systemic lupus erythematosus: Methodological aspects, regulatory landscape and future opportunities 158
Tapering Canakinumab Monotherapy in Patients with Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results from an Open‐label, Randomized Phase IIIb/IV Study 156
Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study. 153
The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 149
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry 148
An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA) 148
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 140
American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus 139
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study 139
Current and future perspectives in the management of juvenile idiopathic arthritis 133
Current medical treatments for juvenile idiopathic arthritis 127
Treatment of juvenile idiopathic arthritis: what's new? 126
Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative 124
Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis 124
The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry 122
Treating juvenile idiopathic arthritis to target: Recommendations of an international task force 120
The PRINTO juvenile dermatomyositis trial - Authors' reply 119
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: Results from the 5-year long-term extension of the phase III pivotal trials 118
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis 117
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: Results of a multicentre, double-blind, randomised-withdrawal trial 116
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study 114
Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus 113
Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis 106
Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score 103
Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus 102
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: Post hoc radiographic analysis from two randomized controlled trials 102
Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial 101
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: Results of a phase 1, open-label, multicenter study 100
Two-year efficacy and safety of etanercept in pediatric patients with extended oligoarthritis, enthesitisrelated arthritis, or psoriatic arthritis 99
International consensus for a definition of disease flare in lupus 97
Validation of the PEDiatric Behçet’s Disease classification criteria: an evidence-based approach 87
Is it worth including subtalar joint in ultrasound ankle assessment of patients with juvenile idiopathic arthritis? 81
Extrapolation or controlled trials in paediatrics: The current dilemma 80
Disease activity, overweight, physical activity and screen time in a cohort of patients with juvenile idiopathic arthritis 80
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the "comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS" (STARS) trial 78
Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index 75
Validity and Reliability of Four Parent/Patient-Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring 70
Preface 63
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force 61
Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers 59
Outcome Scores in Pediatric Rheumatology 58
Towards the definition of disease phenotypes in paediatric SAPHO syndrome: a national multicentric study 49
null 47
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study 45
Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same way 42
Daily Living Activity Dataset of Juvenile Rheumatic Patients From Wearables Data 32
Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus 30
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial 23
Totale 8.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.605
article - articoli 29.605
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.210
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022555 0 0 30 54 14 62 17 133 61 68 28 88
2022/2023631 59 76 8 44 114 78 16 41 99 8 80 8
2023/2024428 33 47 13 54 43 65 19 30 18 17 22 67
2024/20251.209 38 75 57 64 127 152 104 235 36 72 119 130
2025/20262.437 270 64 96 108 320 178 349 108 208 262 235 239
2026/2027463 240 128 95 0 0 0 0 0 0 0 0 0
Totale 8.251